# Clinical Controls, Inc.

- Location (FDA's records): Grover Beach, CA
- FDA decisions: 18 (1994–2001): 18 510(k) clearances
- Names in FDA's records: Clinical Controls, Inc. (17); Clinical Controls (1)
- Product codes: JJY (4), JJX (4), GIL (3), JJT (3), JZG (1), DIF (1), DGD (1), DCK (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K012907: Liquispx Liquid Saliva or Unrine Drug of Abuse Control (Sep 28, 2001)
- K964278: Whole Blood Glucose Control Level 1,2,and 3/Whole Blood Glucose Linearity Control-LEVEL1,2,3,4,5,and 6 (Nov 22, 1996)
- K962432: Liquispex Urine (Micro)Albumin Control (Jul 5, 1996)
- K955690: Aqueous Ethanol/Ammonia Control Level 1, 2, & 3 (Apr 24, 1996)
- K955691: Serum Volatiles Control Level 1 & 2 (Apr 24, 1996)
- K946265: Fibrinogen High Abnormal Control - Level 3 (Aug 24, 1995)
- K935598: Plasma Fibrinogen Control Level 1/Level 2 (May 2, 1995)
- K946049: Liquispex (TM) Liquid B2M/CRP Control Level 1 and 2 (Feb 10, 1995)

Source page: https://510kreport.com/company/clinical-controls